Yes go figure, I seem to recall another company had a big jump...

Yes go figure, I seem to recall another company had a big jump in price a few years back on news of the FDA granting orphan drug. That was without results to compare with a 15 month ongoing remission that coramsine has seen in a stage 4 patient in the target cancer. It was a different cancer though.
Perhaps it will take a while to register.